急性虚血性脳卒中診断の世界市場レポート 2024

急性虚血性脳卒中診断の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には6.7%の年間複合成長率（CAGR）で29億9,000万米ドルに成長すると予想されています。予測期間中に予想される成長は、遠隔モニタリング技術の統合、患者中心の医療モデルの採用、ウェアラブル機器の組み込み、ポイントオブケア検査機器の開発、移動式脳卒中ユニットの拡大など、さまざまな要因によるものです。予測期間中に予想される主な動向には、画像技術の進歩、診断と治療における人工知能の応用、遺伝子およびバイオマーカー製品の革新、データセキュリティのためのブロックチェーンの使用、ヘルスケアアプリケーションにおける拡張現実の統合が含まれます。これらの動向は総合的に、急性虚血性脳卒中診断とケアの継続的な進化と改善に貢献します。

急性虚血性脳卒中症例の予想される急増は、急性虚血性脳卒中診断市場の予想される成長の原動力となっています。この病状は脳への血液供給不足に起因し、重度の脳細胞損傷を引き起こし、重大な医学的緊急事態に該当します。急性虚血性脳卒中を迅速に診断することは、その治療に役立ち、潜在的な脳損傷を軽減し、その後の影響を抑えることができます。米国だけでも年間脳卒中発生件数は79万5,000件を超えており、約610,000件は初めての脳卒中であり、これらの脳卒中のうち約87%は本質的に虚血性であり、脳への血流障害を示しています。したがって、急性虚血性脳卒中症例の蔓延が急性虚血性脳卒中診断市場の拡大を促進します。

急増する高齢者層は、近い将来、急性虚血性脳卒中診断市場の成長に大きく貢献すると見込まれています。 65歳以上の個人として定義されるこの人口統計セグメントは、複数の慢性疾患の蔓延や身体的制限など、老化プロセスに関連する脆弱性と併せて、独特の健康および社会的要件を示しています。高齢者の人口統計は、主に若い年齢層と比較して感受性が高いため、急性虚血性脳卒中診断において極めて重要な役割を果たします。 急性虚血性脳卒中診断で重要な重要な側面には、早期発見、治療法、併発する健康状態が含まれます。たとえば、2022年10月に世界保健機関が発表した洞察によると、2030年までに世界の6人に1人が60歳を超え、その数は2020年の10億人から増加して14億人に達するといいます。 60歳以上の人口は2050年までに21億人に倍増すると予測されており、この期間中にさらに4億2,600万人が80年の節目を超えると予想されています。したがって、高齢者人口の急増は、急性虚血性脳卒中診断市場の拡大を推進する重要な触媒となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の急性虚血性脳卒中診断市場、診断タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• コンピュータ断層撮影（CT）
• 磁気共鳴画像法（MRI）
• 頸動脈超音波検査
• 脳血管造影
• 心電図検査（ECG）
• 心エコー検査
• その他の診断
• 世界の急性虚血性脳卒中診断市場、手術タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 頸動脈内膜切除術
• 血管形成術
• 血管内機械的血栓除去術
• 世界の急性虚血性脳卒中診断市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 組織プラスミノーゲンアクチベーター（tPA）
• 抗凝固剤
• 抗血小板
• 降圧剤

第7章 地域および国の分析

• 世界の急性虚血性脳卒中診断市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の急性虚血性脳卒中診断市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 急性虚血性脳卒中診断市場の競合情勢
• 急性虚血性脳卒中診断市場の企業プロファイル
  • Cardinal Health Inc.
  • Johnson &Johnson Services Inc.
  • Merck &Co. Inc.
  • Bayer AG
  • Sanofi-Aventis LLC

第31章 その他の大手および革新的な企業

• Abbott Laboratories
• Medtronic plc
• Siemens Healthineers AG
• Philips Healthcare
• Stryker Corporation
• GE HealthCare Technologies Inc.
• Boston Scientific Corporation
• Genentech Inc.
• Nihon Kohden Corporation
• Neusoft Medical Systems Co. Ltd.
• Penumbra Inc.
• Insera Therapeutics LLC
• MicroVention Inc.
• FUJIFILM Medical Systems
• Canon Medical Systems Corporation

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

An acute ischemic stroke (AIS) diagnosis involves identifying a medical condition characterized by a sudden loss of blood flow to a specific part of the brain, leading to a loss of neurological function. The diagnostic process aims to pinpoint and understand the origins of the clot responsible for the abrupt reduction in blood flow.

The primary types of acute ischemic stroke diagnosis include computed tomography (CT), magnetic resonance imaging (MRI), carotid ultrasound, cerebral angiography, electrocardiography (ECG), echocardiography, and other relevant methods. Computed tomography (CT) involves the creation of detailed images of various body parts using computer technology connected to an X-ray machine. Various types of surgeries are associated with acute ischemic stroke treatment, including carotid endarterectomy, angioplasty, and endovascular mechanical thrombectomy. These surgical procedures find application in various treatment approaches, such as the use of tissue plasminogen activator (TPA), anticoagulants, antiplatelet medications, and antihypertensive drugs.

The acute ischemic stroke diagnosis market research report is one of a series of new reports from The Business Research Company that provides acute ischemic stroke diagnosis market statistics, including acute ischemic stroke diagnosis industry global market size, regional shares, competitors with an acute ischemic stroke diagnosis market share, detailed acute ischemic stroke diagnosis market segments, market trends and opportunities, and any further data you may need to thrive in the acute ischemic stroke diagnosis industry. This acute ischemic stroke diagnosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The acute ischemic stroke diagnosis market size has grown strongly in recent years. It will grow from $2.14 billion in 2023 to $2.31 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth observed in the historical period can be attributed to several factors, including the rise in cardiovascular risk factors, increased adoption of telemedicine, the establishment of specialized stroke centers, a growing aging population, and advancements in thrombolytic therapies. These elements collectively contributed to the overall progress and improvement in the field of acute ischemic stroke diagnosis and treatment.

The acute ischemic stroke diagnosis market size is expected to see strong growth in the next few years. It will grow to $2.99 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The anticipated growth in the forecast period can be attributed to various factors, including the integration of remote monitoring technologies, the adoption of patient-centric healthcare models, the incorporation of wearable devices, the development of point-of-care testing devices, and the expansion of mobile stroke units. Key trends expected in the forecast period include advancements in imaging technologies, the application of artificial intelligence in diagnostics and treatment, innovations in genetic and biomarker products, the use of blockchain for data security, and the integration of augmented reality in healthcare applications. These trends collectively contribute to the continued evolution and improvement of acute ischemic stroke diagnosis and care.

The anticipated surge in acute ischemic stroke cases stands as a driving force behind the projected growth of the acute ischemic stroke diagnosis market. This medical condition, stemming from inadequate blood supply to the brain, leads to severe brain cell damage and qualifies as a critical medical emergency. Prompt diagnosis of acute ischemic stroke becomes instrumental in its treatment, mitigating potential brain damage, and curtailing subsequent repercussions. An illustrative instance from March 2023 reported by the Centers for Disease Control and Prevention highlighted an increase in stroke-related fatalities from 38.8 per 100,000 in 2020 to 41.1 per 100,000 in 2021. In the United States alone, the annual occurrence exceeds 795,000 strokes, with approximately 610,000 being first-time strokes, and approximately 87% of these strokes are ischemic in nature, indicating impaired blood flow to the brain. Hence, the escalating prevalence of acute ischemic stroke cases drives the expansion of the acute ischemic stroke diagnosis market.

The burgeoning elderly demographic is poised to significantly contribute to the growth of the acute ischemic stroke diagnosis market in the foreseeable future. Defined as individuals aged 65 and above, this demographic segment presents distinct health and social requisites coupled with vulnerabilities associated with the aging process, such as the prevalence of multiple chronic ailments and physical limitations. The elderly demographic assumes a pivotal role in acute ischemic stroke diagnosis, primarily due to their heightened susceptibility compared to younger age groups. Key facets crucial in acute ischemic stroke diagnosis encompass early identification, treatment modalities, and concurrent health conditions. For instance, insights from the World Health Organization in October 2022 indicated that by 2030, 1 in every 6 individuals globally will surpass 60 years of age, reaching a tally of 1.4 billion, up from 1 billion in 2020. Moreover, the worldwide population aged 60 and above is projected to double to 2.1 billion by 2050, with an additional 426 million individuals expected to cross the 80-year milestone during this period. Hence, the burgeoning elderly populace is a significant catalyst propelling the expansion of the acute ischemic stroke diagnosis market.

The acute ischemic stroke diagnosis market is witnessing a prominent trend favoring product innovations, capturing widespread attention. Leading companies within this domain are dedicatedly engaged in pioneering novel products to uphold their market standing. An exemplary instance occurred in February 2022 when Imperative Care Inc., a US-based manufacturer of medical equipment, unveiled the Zoom POD Aspiration Tubing-an innovative advancement aimed at enhancing stroke therapy. Distinguished as the first sterile field clot filter device, the Zoom POD facilitates expedited mechanical thrombectomy procedures for individuals afflicted with ischemic stroke. This groundbreaking device integrates seamlessly into the aspiration tube, significantly reducing the distance between aspiration and filtration while maintaining optimal aspiration strength. The Zoom POD expedites a critical phase of treatment by providing swift visualization to physicians, confirming efficient clot removal, thereby streamlining the therapeutic process.

Major players in the acute ischemic stroke diagnosis market are strategically forging partnerships to gain a competitive edge. These collaborations are strategically aimed at bolstering the development and accessibility of cutting-edge diagnostic tools crucial for accurate and timely stroke diagnosis. Notably, in October 2023, Brainomix Ltd., a US-based medtech company powered by AI solutions, joined forces with Nanoflex Robotics AG, a Switzerland-based developer specializing in soft robotic systems. Their partnership targets the creation of an AI robotics platform dedicated to acute ischemic stroke treatment. This innovative platform involves AI-assisted magnetic navigation systems tailored for stroke-related robotic surgical tools. The amalgamation of their technologies aims to introduce an AI-driven navigation tool facilitating catheters and other devices in navigating the vascular system. This collaborative project aspires to leverage artificial intelligence to enhance Nanoflex Robotics' advanced magnetic robotic navigation system, potentially pioneering remote thrombectomy-a groundbreaking shift in stroke therapy possibilities. This groundbreaking endeavor is anticipated to significantly impact stroke therapy, potentially enhancing patient outcomes by revolutionizing the treatment landscape.

In November 2021, Royal Philips, a Netherlands-based hospital and healthcare company, completed the acquisition of Cardiologs for an undisclosed amount. This strategic move allowed Philips to enhance its cardiac monitoring and diagnostics portfolio by incorporating innovative software technologies, electrocardiogram (ECG) analysis, and reporting services. Cardiologs, based in France, is a medical technology company specializing in ECG, a diagnostic tool relevant to acute ischemic stroke and other cardiovascular conditions.

Major companies operating in the acute ischemic stroke diagnosis market report are Cardinal Health Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Sanofi-Aventis LLC, Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Philips Healthcare, Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Genentech Inc., Nihon Kohden Corporation, Neusoft Medical Systems Co. Ltd., Penumbra Inc., Insera Therapeutics LLC, MicroVention Inc., FUJIFILM Medical Systems, Canon Medical Systems Corporation, Silk Road Medical Inc., Samsung Neurologica Corporation, Mentice AB, NICO Corporation, Imperative Care Inc., Olea Medical, NovaSignal Corporation, iSchemaView Inc., Hyperfine Research Inc., Perfuze Ltd.

North America was the largest region in the acute ischemic stroke diagnosis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute ischemic stroke diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the acute ischemic stroke diagnosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The acute ischemic stroke (AIS) diagnosis market includes revenues earned by entities through physical exams, thrombolysis, blood tests, and other imaging techniques. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Acute Ischemic Stroke Diagnosis Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on acute ischemic stroke diagnosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for acute ischemic stroke diagnosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The acute ischemic stroke diagnosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Diagnostic Type: Computed Tomography (CT); Magnetic Resonance Imaging (MRI); Carotid Ultrasound; Cerebral Angiography; Electrocardiography (ECG); Echocardiography; Other Diagnostics
• 2) By Surgery Type: Carotid Endarterectomy; Angioplasty; Endovascular Mechanical Thrombectomy
• 3) By Application: Tissue Plasminogen Activator (TPA); Anticoagulant; Antiplatelet; Antihypertensive
• Companies Mentioned: Cardinal Health Inc.; Johnson & Johnson Services Inc.; Merck & Co. Inc.; Bayer AG; Sanofi-Aventis LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Acute Ischemic Stroke Diagnosis Market Characteristics

3. Acute Ischemic Stroke Diagnosis Market Trends And Strategies

4. Acute Ischemic Stroke Diagnosis Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Acute Ischemic Stroke Diagnosis Market Size and Growth

• 5.1. Global Acute Ischemic Stroke Diagnosis Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Acute Ischemic Stroke Diagnosis Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Acute Ischemic Stroke Diagnosis Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Acute Ischemic Stroke Diagnosis Market Segmentation

• 6.1. Global Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Computed Tomography (CT)
• Magnetic Resonance Imaging (MRI)
• Carotid Ultrasound
• Cerebral Angiography
• Electrocardiography (ECG)
• Echocardiography
• Other Diagnostics
• 6.2. Global Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Carotid Endarterectomy
• Angioplasty
• Endovascular Mechanical Thrombectomy
• 6.3. Global Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Tissue Plasminogen Activator (tPA)
• Anticoagulant
• Antiplatelet
• Antihypertensive

7. Acute Ischemic Stroke Diagnosis Market Regional And Country Analysis

• 7.1. Global Acute Ischemic Stroke Diagnosis Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Acute Ischemic Stroke Diagnosis Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Acute Ischemic Stroke Diagnosis Market

• 8.1. Asia-Pacific Acute Ischemic Stroke Diagnosis Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Acute Ischemic Stroke Diagnosis Market

• 9.1. China Acute Ischemic Stroke Diagnosis Market Overview
• 9.2. China Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Acute Ischemic Stroke Diagnosis Market

• 10.1. India Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Acute Ischemic Stroke Diagnosis Market

• 11.1. Japan Acute Ischemic Stroke Diagnosis Market Overview
• 11.2. Japan Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Acute Ischemic Stroke Diagnosis Market

• 12.1. Australia Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Acute Ischemic Stroke Diagnosis Market

• 13.1. Indonesia Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Acute Ischemic Stroke Diagnosis Market

• 14.1. South Korea Acute Ischemic Stroke Diagnosis Market Overview
• 14.2. South Korea Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Acute Ischemic Stroke Diagnosis Market

• 15.1. Western Europe Acute Ischemic Stroke Diagnosis Market Overview
• 15.2. Western Europe Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Acute Ischemic Stroke Diagnosis Market

• 16.1. UK Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Acute Ischemic Stroke Diagnosis Market

• 17.1. Germany Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Acute Ischemic Stroke Diagnosis Market

• 18.1. France Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Acute Ischemic Stroke Diagnosis Market

• 19.1. Italy Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Acute Ischemic Stroke Diagnosis Market

• 20.1. Spain Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Acute Ischemic Stroke Diagnosis Market

• 21.1. Eastern Europe Acute Ischemic Stroke Diagnosis Market Overview
• 21.2. Eastern Europe Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Acute Ischemic Stroke Diagnosis Market

• 22.1. Russia Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Acute Ischemic Stroke Diagnosis Market

• 23.1. North America Acute Ischemic Stroke Diagnosis Market Overview
• 23.2. North America Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Acute Ischemic Stroke Diagnosis Market

• 24.1. USA Acute Ischemic Stroke Diagnosis Market Overview
• 24.2. USA Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Acute Ischemic Stroke Diagnosis Market

• 25.1. Canada Acute Ischemic Stroke Diagnosis Market Overview
• 25.2. Canada Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Acute Ischemic Stroke Diagnosis Market

• 26.1. South America Acute Ischemic Stroke Diagnosis Market Overview
• 26.2. South America Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Acute Ischemic Stroke Diagnosis Market

• 27.1. Brazil Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Acute Ischemic Stroke Diagnosis Market

• 28.1. Middle East Acute Ischemic Stroke Diagnosis Market Overview
• 28.2. Middle East Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Acute Ischemic Stroke Diagnosis Market

• 29.1. Africa Acute Ischemic Stroke Diagnosis Market Overview
• 29.2. Africa Acute Ischemic Stroke Diagnosis Market, Segmentation By Diagnostic Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Acute Ischemic Stroke Diagnosis Market, Segmentation By Surgery Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Acute Ischemic Stroke Diagnosis Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Acute Ischemic Stroke Diagnosis Market Competitive Landscape And Company Profiles

• 30.1. Acute Ischemic Stroke Diagnosis Market Competitive Landscape
• 30.2. Acute Ischemic Stroke Diagnosis Market Company Profiles
  • 30.2.1. Cardinal Health Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Johnson & Johnson Services Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Merck & Co. Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Bayer AG
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Sanofi-Aventis LLC
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Acute Ischemic Stroke Diagnosis Market Other Major And Innovative Companies

• 31.1. Abbott Laboratories
• 31.2. Medtronic plc
• 31.3. Siemens Healthineers AG
• 31.4. Philips Healthcare
• 31.5. Stryker Corporation
• 31.6. GE HealthCare Technologies Inc.
• 31.7. Boston Scientific Corporation
• 31.8. Genentech Inc.
• 31.9. Nihon Kohden Corporation
• 31.10. Neusoft Medical Systems Co. Ltd.
• 31.11. Penumbra Inc.
• 31.12. Insera Therapeutics LLC
• 31.13. MicroVention Inc.
• 31.14. FUJIFILM Medical Systems
• 31.15. Canon Medical Systems Corporation

32. Global Acute Ischemic Stroke Diagnosis Market Competitive Benchmarking

33. Global Acute Ischemic Stroke Diagnosis Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Acute Ischemic Stroke Diagnosis Market

35. Acute Ischemic Stroke Diagnosis Market Future Outlook and Potential Analysis

• 35.1 Acute Ischemic Stroke Diagnosis Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Acute Ischemic Stroke Diagnosis Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Acute Ischemic Stroke Diagnosis Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer